From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy

Abstract Chimeric antigen receptor T (CAR‐T) cell therapies, a cornerstone of immunotherapy, have demonstrated remarkable efficacy in treating hematological malignancies and have more recently expanded into applications for solid tumors and autoimmune diseases. Emerging multidimensional profiling te...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuting Gong, Peng Fei, Yicheng Zhang, Yang Xu, Jia Wei
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202501095
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850235457313439744
author Yuting Gong
Peng Fei
Yicheng Zhang
Yang Xu
Jia Wei
author_facet Yuting Gong
Peng Fei
Yicheng Zhang
Yang Xu
Jia Wei
author_sort Yuting Gong
collection DOAJ
description Abstract Chimeric antigen receptor T (CAR‐T) cell therapies, a cornerstone of immunotherapy, have demonstrated remarkable efficacy in treating hematological malignancies and have more recently expanded into applications for solid tumors and autoimmune diseases. Emerging multidimensional profiling technologies offer promising solutions for enhancing CAR‐T efficacy, overcoming resistance, and facilitating the development of novel CAR‐T constructs. The integration of genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics enables a comprehensive understanding of the intrinsic mechanisms underlying CAR‐T therapy, while single‐cell and spatial omics significantly improve data resolution and analytical depth. Coupled with advances in biomedical engineering, visualization technologies form the foundation for omics data generation by bridging microscopic and macroscopic scales and enabling dynamic, 3D in vivo monitoring of CAR‐T behavior. Artificial intelligence (AI) further supports this framework by enabling the analysis of complex, high‐dimensional datasets. This review highlights recent advances in the integration of multidimensional omics within CAR‐T therapy and explores cutting‐edge developments in visualization technologies and AI applications. The full convergence of multi‐omics, visualization tools, and AI is poised to deliver transformative insights into the mechanisms governing CAR‐T cell therapy.
format Article
id doaj-art-91b1016d7f2e40f4b62a6bee97e80a4e
institution OA Journals
issn 2198-3844
language English
publishDate 2025-05-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-91b1016d7f2e40f4b62a6bee97e80a4e2025-08-20T02:02:15ZengWileyAdvanced Science2198-38442025-05-011220n/an/a10.1002/advs.202501095From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell TherapyYuting Gong0Peng Fei1Yicheng Zhang2Yang Xu3Jia Wei4Department of Hematology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430030 ChinaDepartment of Hematology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430030 ChinaDepartment of Hematology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430030 ChinaNational Clinical Research Center for Hematologic Diseases Jiangsu Institute of Hematology The First Affiliated Hospital of Soochow University Suzhou Jiangsu 215006 ChinaDepartment of Hematology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei 430030 ChinaAbstract Chimeric antigen receptor T (CAR‐T) cell therapies, a cornerstone of immunotherapy, have demonstrated remarkable efficacy in treating hematological malignancies and have more recently expanded into applications for solid tumors and autoimmune diseases. Emerging multidimensional profiling technologies offer promising solutions for enhancing CAR‐T efficacy, overcoming resistance, and facilitating the development of novel CAR‐T constructs. The integration of genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics enables a comprehensive understanding of the intrinsic mechanisms underlying CAR‐T therapy, while single‐cell and spatial omics significantly improve data resolution and analytical depth. Coupled with advances in biomedical engineering, visualization technologies form the foundation for omics data generation by bridging microscopic and macroscopic scales and enabling dynamic, 3D in vivo monitoring of CAR‐T behavior. Artificial intelligence (AI) further supports this framework by enabling the analysis of complex, high‐dimensional datasets. This review highlights recent advances in the integration of multidimensional omics within CAR‐T therapy and explores cutting‐edge developments in visualization technologies and AI applications. The full convergence of multi‐omics, visualization tools, and AI is poised to deliver transformative insights into the mechanisms governing CAR‐T cell therapy.https://doi.org/10.1002/advs.202501095artificial intelligenceCAR‐T therapymulti‐omicssingle cell sequencingspatial omicstumor microenvironment
spellingShingle Yuting Gong
Peng Fei
Yicheng Zhang
Yang Xu
Jia Wei
From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy
Advanced Science
artificial intelligence
CAR‐T therapy
multi‐omics
single cell sequencing
spatial omics
tumor microenvironment
title From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy
title_full From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy
title_fullStr From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy
title_full_unstemmed From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy
title_short From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy
title_sort from multi omics to visualization and beyond bridging micro and macro insights in car t cell therapy
topic artificial intelligence
CAR‐T therapy
multi‐omics
single cell sequencing
spatial omics
tumor microenvironment
url https://doi.org/10.1002/advs.202501095
work_keys_str_mv AT yutinggong frommultiomicstovisualizationandbeyondbridgingmicroandmacroinsightsincartcelltherapy
AT pengfei frommultiomicstovisualizationandbeyondbridgingmicroandmacroinsightsincartcelltherapy
AT yichengzhang frommultiomicstovisualizationandbeyondbridgingmicroandmacroinsightsincartcelltherapy
AT yangxu frommultiomicstovisualizationandbeyondbridgingmicroandmacroinsightsincartcelltherapy
AT jiawei frommultiomicstovisualizationandbeyondbridgingmicroandmacroinsightsincartcelltherapy